This case highlights the need for immunohistochemical profiling of patients with multiple breast nodules and a history of ...

Eosinophilic Esophagitis: Empowering Clinicians for Better Patient Outcomes This program is supported by an independent educational grant from Regeneron Pharmaceuticals, Inc. and Sanofi.

GSK’s follow-up to its severe asthma therapy Nucala has shown its value in a pair of phase 3 trials, reducing exacerbations compared to placebo with dosing once every six months.

IL-4 and IL-13 inhibitor Dupixent (dupilumab) is currently approved as an add-on treatment for moderate-to-severe asthma characterised by an eosinophilic phenotype – a specific form of ...

Etrasimod led to sustained histological and endoscopic improvements in eosinophilic oesophagitis over 52 weeks, symptom improvement in patients without dilation, and was well tolerated. This trial ...

BACKGROUND Eosinophils play a pivotal role in asthmatic airway inflammation. Apoptosis is thought to be critically relevant in promoting the clearance of inflammatory cells and the resolution of ...